To study the medical characteristics and genetic foundation of complete androgen insensitivity syndrome (CAIS) in sufferers from the People’s Republic of China. CAIS sufferers with 46 XY karyotype produce male ranges of androgens however current with feminine exterior genitalia and secondary intercourse characteristics. The majority of affected people have androgen receptor (AR) gene mutations. This case series explored medical and molecular characteristics of CAIS sufferers from the People’s Republic of China. Genomic DNA from peripheral blood of clinically recognized CAIS sufferers was sequenced for mutation within the androgen receptor (AR) gene and steroid 5α-reductase sort 2 gene (SRD5A2).
A Qualtrics survey was despatched to doctor trainees who rotated in genetics earlier than or midpandemic. Questions assessed affected person care, didactic schooling, and competency in a number of domains. Number of clinic visits accomplished by trainees had been collated by way of overview of documentation. Twenty-three rotating residents accomplished the surveys. Five of the pediatric residents accomplished the elective through the pandemic. All residents participated in digital care through the pandemic, and rotating residents reported an enchancment in self-assessed competency in a number of domains. Potential weak areas of schooling midpandemic included dysmorphology and genetic counseling.
Participants had been recruited from Peking Union Medical College Hospital once they got here in for session. Thirty sufferers from unrelated households had been recruited. Data from medical paperwork recording analysis and therapy of these sufferers had been retrospectively collected. Patient genotypes had been decided by sequencing the AR and SRD5A2 genes. Their medical characteristics had been summarized based mostly on Twenty-one sufferers recognized with CAIS had mutations in AR exons. Analysis of AR exons revealed the presence of seven novel mutations; of these mutations, 47.6% (10/21) had been situated within the ligand-binding area. Gonadal insufficiency was present in one case of CAIS. Among the remaining 9 sufferers, three had SRD5A2 mutations and due to this fact a steroid 5α-reductase deficiency. No AR or SRD5A2 mutations had been detected within the different six sufferers.
20-year expertise on prenatal analysis in a reference college medical genetics center in Turkey
Although leading edge procedures similar to cell-free fetal DNA isolation from maternal blood are actually accessible, invasive prenatal assessments are nonetheless getting used extensively for prenatal analysis. The purpose of this study is to judge the demographic knowledge, indications and cytogenetic outcomes of 9297 outcomes of sufferers who underwent prenatal invasive testing for genetic evaluation that had been referred for the final 20 years in a University Medical Genetics Center. The data of 8363 amniocentesis, 626 chorionic villus and 308 cordocentesis samples had been retrospectively evaluated and analyzed in regard to referral causes, indications and their cytogenetic outcomes. The whole numbers and the chances of every group had been recorded; Chi-square and logistic regression evaluation had been carried out as a way to give the statistical chance of completely different occasions.
The quantity of referrals decreased considerably after 2009. Risk of having trisomy 21 in addition to trisomy 13 and 18 considerably elevated in parallel with superior maternal age. When the 21-25 age group was in comparison with the older age teams in phrases of having a trisomy 21 being pregnant, the danger doubled within the 36-40, 5 occasions increased in 41-45 and 10-fold in 46-50 age teams. No important linear correlation between maternal serum screening take a look at outcomes and trisomy 21 was discovered, nevertheless the distinction between the pregnancies whom cut-off worth above and beneath 1/250 in maternal serum screening take a look at had been important.
These knowledge have offered helpful data on the frequency of referrals to the reference genetics division, and the feasibility of genetic companies. By reviewing the indications and their corresponding outcomes, we will supply invaluable insights that shall be helpful in genetic counseling and additionally within the improvement of more practical genetic methods.
Barriers and methods to combine medical genetics and main care in underserved populations: a scoping overview
Despite medical and technological advances, critical gaps stay in delivering genetic companies on account of disparities in workforce distribution and lack of protection for genetic testing and counseling. Genetic companies supply, notably in medically underserved populations, might rely closely on main care suppliers (PCPs). This study goals to establish boundaries to integrating genetic companies and main care, and methods to assist integration, by conducting a scoping overview.
Literature synthesis discovered boundaries most regularly cited by PCPs together with inadequate information about genetics and danger evaluation, lack of entry to geneticists, and inadequate time to deal with these challenges. Telegenetics, patient-centered care, and studying communities are methods to beat these boundaries. Telegenetics dietary supplements face-to-face clinics by offering distant entry to genetic companies. It can also be used for doctor consultations and schooling. Patient-centered care permits suppliers, households, and sufferers to coordinate companies and sources. Access to skilled data gives a important useful resource for PCPs.
 anti-Tissue Factor |
|||
| YF-PA11659 | Abfrontier | 100 ul | EUR 403 |
|
Description: Rabbit polyclonal to Tissue Factor |
|||
|
anti-Tissue Factor |
|||
| YF-PA11660 | Abfrontier | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal to Tissue Factor |
|||
 Anti-Tissue Factor/F3 Antibody |
|||
| PB9701 | BosterBio | 100ug/vial | EUR 294 |
|
Anti-Tissue Factor/F3 Antibody |
|||
| PB9702 | BosterBio | 100ug/vial | EUR 294 |
) Anti-Tissue Factor (4G4) |
|||
| YF-MA12922 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to Tissue Factor |
|||
|
Anti-Tissue Factor (4G4) |
|||
| YF-MA12923 | Abfrontier | 200 ul | EUR 363 |
|
Description: Mouse monoclonal to Tissue Factor |
|||
 Anti-Tissue Factor Rabbit Monoclonal Antibody |
|||
| M00342 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Rabbit Monoclonal Tissue Factor Antibody. Validated in IF, IHC-P, ICC, WB and tested in Human, Mouse, Rat. |
|||
 Anti-Connective Tissue Growth Factor antibody |
|||
| STJ73587 | St John's Laboratory | 100 µg | EUR 359 |
 Anti-Tissue Factor Pathway Inhibitor antibody |
|||
| STJ70019 | St John's Laboratory | 100 µg | EUR 359 |
 Tissue Factor antibody |
|||
| 20R-1401 | Fitzgerald | 10 mg | EUR 303 |
|
Description: Sheep polyclonal Tissue Factor antibody |
|||
 Tissue Factor Antibody |
|||
| 49112-100ul | SAB | 100ul | EUR 333 |
|
Tissue Factor Antibody |
|||
| 49112-50ul | SAB | 50ul | EUR 239 |
 Sheep anti-Human Tissue Factor polyclonal antibody |
|||
| CABT-L422 | Creative Diagnostics | 10 mg | EUR 663 |
|
Sheep anti-Human Tissue Factor polyclonal antibody |
|||
| CABT-L423 | Creative Diagnostics | 200ug | EUR 663 |
 Mouse anti-Human Tissue Factor monoclonal antibody |
|||
| CABT-L424 | Creative Diagnostics | 100ug | EUR 663 |
|
Mouse anti-Human Tissue Factor monoclonal antibody |
|||
| CABT-L425 | Creative Diagnostics | 100ug | EUR 663 |
) Tissue Factor antibody (HRP) |
|||
| 60R-1016 | Fitzgerald | 200 ug | EUR 358 |
|
Description: Sheep polyclonal Tissue Factor antibody (HRP) conjugated |
|||
) Tissue Factor antibody (FITC) |
|||
| 60R-1056 | Fitzgerald | 100 ug | EUR 418 |
|
Description: Sheep polyclonal Tissue Factor antibody (FITC) conjugated |
|||
) Tissue Factor antibody (biotin) |
|||
| 60R-1057 | Fitzgerald | 100 ug | EUR 418 |
|
Description: Sheep polyclonal Tissue Factor antibody (biotin) conjugated |
|||
 Antibody) Tissue Factor (TF) Antibody |
|||
| 20-abx178602 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx178604 | Abbexa |
|
|
|
|||
 Antibody) Tissue factor (F3) Antibody |
|||
| 20-abx210516 | Abbexa |
|
|
|
|||
 Antibody) Tissue Factor (F3) Antibody |
|||
| 20-abx100873 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx100874 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx100875 | Abbexa |
|
|
|
|||
|
Tissue Factor (F3) Antibody |
|||
| 20-abx100876 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx100877 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx100878 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx104870 | Abbexa |
|
|
|
|||
|
Tissue Factor (F3) Antibody |
|||
| abx117088-100ug | Abbexa | 100 ug | EUR 467 |
|
|||
|
Tissue Factor (F3) Antibody |
|||
| abx037991-100ug | Abbexa | 100 ug | EUR 391 |
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx132340 | Abbexa |
|
|
|
|||
 Antibody) Tissue Factor (CD142) Antibody |
|||
| abx140398-01mg | Abbexa | 0.1 mg | EUR 356 |
|
|||
|
Tissue Factor (CD142) Antibody |
|||
| 20-abx141195 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx174801 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx174802 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx174803 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx270078 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx270129 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody |
|||
| 20-abx270230 | Abbexa |
|
|
|
|||
 Tissue Factor Conjugated Antibody |
|||
| C49112 | SAB | 100ul | EUR 397 |
|
Tissue Factor (CD142) Antibody |
|||
| abx411647-01mg | Abbexa | 0.1 mg | EUR 439 |
|
|||
|
Tissue Factor (CD142) Antibody |
|||
| abx414339-02mg | Abbexa | 0.2 mg | EUR 565 |
|
|||
|
Tissue factor (F3) Antibody |
|||
| 20-abx339467 | Abbexa |
|
|
|
|||
|
Tissue factor (F3) Antibody |
|||
| 20-abx323788 | Abbexa |
|
|
|
|||
|
Tissue factor (F3) Antibody |
|||
| 20-abx325045 | Abbexa |
|
|
|
|||
|
Tissue Factor (F3) Antibody |
|||
| 20-abx303791 | Abbexa |
|
|
|
|||
|
Tissue Factor (F3) Antibody |
|||
| 20-abx001211 | Abbexa |
|
|
|
|||
 Polyclonal Goat Anti-Tissue Factor Pathway Inhibitor Antibody |
|||
| APG00335G | Leading Biology | 0.1mg | EUR 484 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-Tissue Factor Pathway Inhibitor . This antibody is tested and proven to work in the following applications: |
|||
 Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
 Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280 |
 Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280 |
 Mouse Monoclonal Anti-Human Tissue Factor IgG |
|||
| TIF11-M | Alpha Diagnostics | 100 ug | EUR 482 |
 Antibody) Mouse Tissue Factor (TF) Antibody |
|||
| 32800-05111 | AssayPro | 150 ug | EUR 261 |
 Antibody) Human Tissue Factor (TF) Antibody |
|||
| 11611-05011 | AssayPro | 150 ug | EUR 217 |
 Antibody (APC)) Tissue Factor (TF) Antibody (APC) |
|||
| 20-abx178603 | Abbexa |
|
|
|
|||
 Antibody (FITC)) Tissue Factor (TF) Antibody (FITC) |
|||
| 20-abx270376 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (FITC) |
|||
| 20-abx270427 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (FITC) |
|||
| 20-abx270528 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (APC) |
|||
| 20-abx270608 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (APC) |
|||
| 20-abx270659 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (APC) |
|||
| 20-abx270760 | Abbexa |
|
|
|
|||
 Antibody (PE)) Tissue Factor (TF) Antibody (PE) |
|||
| 20-abx270840 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (PE) |
|||
| 20-abx270891 | Abbexa |
|
|
|
|||
 Antibody (FITC)) Tissue Factor (CD142) Antibody (FITC) |
|||
| abx414337-01mg | Abbexa | 0.1 mg | EUR 509 |
|
|||
|
Tissue Factor (CD142) Antibody (FITC) |
|||
| abx414338-25ug | Abbexa | 25 ug | EUR 272 |
|
|||
|
Tissue Factor (TF) Antibody (PE) |
|||
| 20-abx270992 | Abbexa |
|
|
|
|||
 Antibody (Biotin)) Tissue Factor (TF) Antibody (Biotin) |
|||
| 20-abx271994 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (Biotin) |
|||
| 20-abx272699 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (Biotin) |
|||
| 20-abx273044 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (Biotin) |
|||
| 20-abx273176 | Abbexa |
|
|
|
|||
 Antibody Pair) Tissue Factor (TF) Antibody Pair |
|||
| 20-abx370347 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (FITC) |
|||
| 20-abx273794 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (FITC) |
|||
| 20-abx274001 | Abbexa |
|
|
|
|||
|
Tissue Factor (TF) Antibody (FITC) |
|||
| 20-abx274137 | Abbexa |
|
|
|
|||
 Antibody (HRP)) Tissue Factor (F3) Antibody (HRP) |
|||
| 20-abx303792 | Abbexa |
|
|
|
|||
 Antibody (FITC)) Tissue Factor (F3) Antibody (FITC) |
|||
| 20-abx303793 | Abbexa |
|
|
|
|||
 Antibody (Biotin)) Tissue Factor (F3) Antibody (Biotin) |
|||
| 20-abx303794 | Abbexa |
|
|
|
|||
 Tissue Factor recombinant monoclonal antibody |
|||
| A5658 | Bimake | 100ul X 3 | EUR 595 |
|
|||
|
Description: A recombinant monoclonal antibody from rabbit against human Tissue Factor for WB, IHC, IF,ELISA |
|||
 Sheep anti-Human Tissue Factor Pathway Inhibitor polyclonal antibody |
|||
| CABT-L505 | Creative Diagnostics | 10 mg | EUR 663 |
 Connective tissue growth factor Polyclonal Antibody |
|||
| 42506-100ul | SAB | 100ul | EUR 333 |
 Antibody) Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx025473-100ul | Abbexa | 100 ul | EUR 523 |
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx027387-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx027387-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 Antibody) Connective tissue growth factor (CTGF) Antibody |
|||
| 20-abx214776 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx175995 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx175996 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx175997 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx103225 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx103226 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx103227 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx103228 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx103229 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx103230 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx103231 | Abbexa |
|
|
|
|||
 Antibody) Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx103325 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx103326 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx103328 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx103329 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx104836 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx104947 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx116110 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx123700 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx125726 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx125727 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx125728 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx037800-100ug | Abbexa | 100 ug | EUR 391 |
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx129517 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx131768 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx132084 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx132085 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx132086 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx132193 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx132350 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx132360 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx109670 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx174804 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx171909 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx171910 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx033675-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx033675-80l | Abbexa | 80 µl | EUR 286 |
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx033676-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx033676-80l | Abbexa | 80 µl | EUR 286 |
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| abx238634-100ug | Abbexa | 100 ug | EUR 551 |
|
|||
 Antibody) Connective Tissue Growth Factor (Ctgf) Antibody |
|||
| 20-abx319302 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx323593 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| abx433382-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx433502-200ul | Abbexa | 200 ul | EUR 453 |
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 20-abx225128 | Abbexa |
|
|
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx232053-100ug | Abbexa | 100 ug | EUR 509 |
|
|||
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
| abx232054-100ug | Abbexa | 100 ug | EUR 509 |
|
|||
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 20-abx001368 | Abbexa |
|
|
|
|||
 Polyclonal Antibody (Bovine)) Tissue Factor (TF) Polyclonal Antibody (Bovine) |
|||
| 4-PAA524Bo01 | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Bovine Tissue Factor (TF) |
|||
 Polyclonal Antibody (Human)) Tissue Factor (TF) Polyclonal Antibody (Human) |
|||
| 4-PAA524Hu01 | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Human Tissue Factor (TF) |
|||
 Polyclonal Antibody (Mouse)) Tissue Factor (TF) Polyclonal Antibody (Mouse) |
|||
| 4-PAA524Mu01 | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Mouse Tissue Factor (TF) |
|||
 Polyclonal Antibody (Rat)) Tissue Factor (TF) Polyclonal Antibody (Rat) |
|||
| 4-PAA524Ra01 | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Rat Tissue Factor (TF) |
|||
 Polyclonal Antibody (Rabbit)) Tissue Factor (TF) Polyclonal Antibody (Rabbit) |
|||
| 4-PAA524Rb51 | Cloud-Clone |
|
|
|
|||
|
Description: A Guinea polyclonal antibody against Rabbit Tissue Factor (TF) |
|||
 Monoclonal Antibody (Human)) Tissue Factor (TF) Monoclonal Antibody (Human) |
|||
| 4-MAA524Hu21 | Cloud-Clone |
|
|
|
|||
|
Description: A Mouse monoclonal antibody against Human Tissue Factor (TF) |
|||
|
Tissue Factor (TF) Monoclonal Antibody (Human) |
|||
| 4-MAA524Hu22 | Cloud-Clone |
|
|
|
|||
|
Description: A Mouse monoclonal antibody against Human Tissue Factor (TF) |
|||
 Monoclonal Antibody (Mouse)) Tissue Factor (TF) Monoclonal Antibody (Mouse) |
|||
| 4-MAA524Mu21 | Cloud-Clone |
|
|
|
|||
|
Description: A Rat monoclonal antibody against Mouse Tissue Factor (TF) |
|||
 Monoclonal Antibody (Rat)) Tissue Factor (TF) Monoclonal Antibody (Rat) |
|||
| 4-MAA524Ra21 | Cloud-Clone |
|
|
|
|||
|
Description: A Mouse monoclonal antibody against Rat Tissue Factor (TF) |
|||
 Monoclonal Antibody (Rabbit)) Tissue Factor (TF) Monoclonal Antibody (Rabbit) |
|||
| 4-MAA524Rb21 | Cloud-Clone |
|
|
|
|||
|
Description: A Mouse monoclonal antibody against Rabbit Tissue Factor (TF) |
|||
) Human Tissue factor (F3) |
|||
| 1-CSB-EP007928HU1 | Cusabio |
|
|
|
|||
|
Description: Recombinant Human Tissue factor(F3),partial expressed in E.coli |
|||
) Active Tissue Factor (TF) |
|||
| 4-APA524Ra01 | Cloud-Clone |
|
|
|
|||
|
Description: Recombinant Rat Tissue Factor expressed in: E.coli |
|||
 CD142/Tissue factor/F3 |
|||
| E21-479 | EnoGene | 10ug | EUR 343 |
 Protein) Tissue Factor (F3) Protein |
|||
| 20-abx262300 | Abbexa |
|
|
|
|||
 Tissue Factor Rabbit mAb |
|||
| A4395-100ul | Abclonal | 100 ul | EUR 410 |
|
Tissue Factor Rabbit mAb |
|||
| A4395-200ul | Abclonal | 200 ul | EUR 571 |
|
Tissue Factor Rabbit mAb |
|||
| A4395-20ul | Abclonal | 20 ul | EUR 221 |
|
Tissue Factor Rabbit mAb |
|||
| A4395-50ul | Abclonal | 50 ul | EUR 287 |
) Recombinant Tissue Factor (TF) |
|||
| 4-RPA524Bo01 | Cloud-Clone |
|
|
|
|||
|
Description: Recombinant Bovine Tissue Factor expressed in: E.coli |
|||
|
Recombinant Tissue Factor (TF) |
|||
| 4-RPA524Hu01 | Cloud-Clone |
|
|
|
|||
|
Description: Recombinant Human Tissue Factor expressed in: E.coli |
|||
|
Recombinant Tissue Factor (TF) |
|||
| 4-RPA524Mu01 | Cloud-Clone |
|
|
|
|||
|
Description: Recombinant Mouse Tissue Factor expressed in: E.coli |
|||
|
Recombinant Tissue Factor (TF) |
|||
| 4-RPA524Ra01 | Cloud-Clone |
|
|
|
|||
|
Description: Recombinant Rat Tissue Factor expressed in: E.coli |
|||
|
Recombinant Tissue Factor (TF) |
|||
| 4-RPA524Rb01 | Cloud-Clone |
|
|
|
|||
|
Description: Recombinant Rabbit Tissue Factor expressed in: E.coli |
|||
 Antibody) Human Connective Tissue Growth Factor (CTGF) Antibody |
|||
| 35148-05111 | AssayPro | 150 ug | EUR 261 |
 Antibody (Biotin Conjugate)) Mouse Tissue Factor (TF) Antibody (Biotin Conjugate) |
|||
| 32800-05121 | AssayPro | 150 ug | EUR 369 |
 Antibody (Biotin Conjugate)) Human Tissue Factor (TF) Antibody (Biotin Conjugate) |
|||
| 11611-05021 | AssayPro | 150 ug | EUR 276 |
 Antibody) Human Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
| 11621-05011 | AssayPro | 150 ug | EUR 217 |
 Antibody) Tissue Factor Pathway Inhibitor 2 (TFPI2) Antibody |
|||
| 20-abx006327 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor 2 (TFPI2) Antibody |
|||
| 20-abx210903 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor 2 (TFPI2) Antibody |
|||
| 20-abx103659 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor 2 (TFPI2) Antibody |
|||
| 20-abx103660 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor 2 (TFPI2) Antibody |
|||
| 20-abx103661 | Abbexa |
|
|
|
|||
|
Tissue Factor Pathway Inhibitor 2 (TFPI2) Antibody |
|||
| 20-abx103662 | Abbexa |
|
|
|
|||
Learning communities might symbolize a mechanism that facilitates data alternate and information sharing amongst completely different suppliers. As PCPs usually play a essential position caring for sufferers with genetic issues in underserved areas, boundaries to main care-medical genetics integration should be addressed to enhance entry. Strategies, similar to telegenetics, promotion of evidence-based tips, point-of-care danger evaluation instruments, tailor-made schooling in genetics-related subjects, and different system-level methods, will facilitate higher genetics and main care integration, which in flip, might enhance genetic service supply to sufferers residing in underserved communities.